Related Experiment Videos
Central dopamine involvement in experimental gastrointestinal injury
1Department of Pharmacology and Therapeutics and Surgery, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Summary
Dopamine D1 agonists reduced gastrointestinal ulcers when administered into the mesolimbic dopamine (DA) tract. Conversely, D1 antagonists worsened these ulcers, indicating D1 receptors
Area of Science:
- Neuroscience
- Gastroenterology
Background:
- Stress and cysteamine induce gastric and duodenal ulcers in rats.
- Dopamine pathways in the brain are implicated in various physiological processes.
Purpose of the Study:
- To investigate the role of dopamine D1 receptors in mediating stress-induced gastrointestinal damage.
- To determine the specific brain regions and dopamine tracts involved.
Main Methods:
- Rats were surgically prepared with intracerebral cannulas for targeted compound delivery.
- Selective dopamine D1 agonists and antagonists were microinjected into specific brain regions.
- Gastric ulcers were induced by cold-restraint stress, and duodenal ulcers by cysteamine.
Main Results:
- Dopamine D1 agonists significantly reduced both gastric and duodenal ulcers when infused into the mesolimbic dopamine tract.
- Agonist administration into the nigrostriatal tract showed minimal effects, while the mesocortical tract showed no effect.
- The D1 antagonist exacerbated ulcers when administered into the mesolimbic tract, with lesser effects in the nigrostriatal tract.
Conclusions:
- Central dopamine D1 receptors, particularly within the mesolimbic dopamine tract, play a crucial role in stress-related gastrointestinal responses.
- Targeting D1 receptors in the mesolimbic pathway may offer a therapeutic strategy for stress-induced gastrointestinal disorders.